Start in 1976 Pyridam established with small factory. In 1985, Pyridam established its Pharmaceutical Division, which develop quickly. Pyridam was awarded the title “Partner with Good Performance” in 1994 by the Ministry of Agriculture and Accelerated improvement enabled Pyridam to build a brand new production plant on 35,000 sqm land in Cianjur, West Java, with state of the art design, machinery, and environmental management. The plant started its operation in April 2001.
PT Pyridam diversified its business by producing and marketing human medicines at the initial stage of its business expansion.
At the same time, the Company was also honored by several overseas principals with marketing rights of their health equipment products in territory of Indonesia, particularly in the laboratory apparatus/equipment sector.Learn More
PT Pyridam started operating its new factory located in Pacet, Cianjur.
In the same year, PT Pyridam completed an Initial Public Offering (IPO) of 120,000,000 ordinary shares, and since then, it was registered at the Jakarta Stock Exchange, which later changed its name to Indonesia Stock Exchange. Following the completion of IPO, the Company name was changed to PT Pyridam Farma, Tbk.Learn More
PT Pyridam Farma, Tbk. obtained ISO certificate 9001:2000 through SGS for all sectors of its businesses.
The organization and all business activities of the Company were therefore, in conformity with the international standard.
In September 2011, the Company had successfully obtained ISO 9001: 2008, upgraded from the previous version ISO 9001: 2000.
This should serve to demonstrate the Company’s determination in maintaining and improving its management system by adopting the newer updated version to meet the international standard.
PT. Pyridam Farma Tbk. succeeded to obtain cGMP certificate after having completed the total renovation of its production facility that had been carried-out since November 2012.
PT Pyridam Farma Tbk. completed its total factory renovation works by mid of 2014 as also adding purified water sysytem utilizing reverse osmosis technology and centralized air conditioning system replacing the old one – to meet the requirements of the current GMP (cGMP). Thereupon, it succeeded to obtain the cGMP certification by the National Food and Drugs Administration (BPOM). Along with the total factory renovation, PT Pyridam Farma Tbk. also carried out its production capacity expansion.
The Company has also obtained Current Good Manufacturing Practices (Traditional Medicine) (CPOTB) for effervescent powder and tablet which is valid until 14 August 2022.
In 2018, the Company succeeded in obtaining a “halal certificate” issued by the relevant authorities, that is, LPPOM – MUI on 12 December 2018 valid until December 11, 2020.
In 2018 the Company succeeded to get cGMP extension for all product processes and dosage forms with a validity period up to September 25, 2023, while cGMP for herbal products is still valid until April 13, 2020.
In 2019, the Company obtained an ISO/IEC 17025: 2017 Certificate.
In 2019, the Company obtained an ISO/IEC 17025: 2017 Certificate as a Testing Laboratory issued by the National Accreditation Committee (KAN) with a validity period until July 22, 2024.
On July 20, 2020, there was a transfer of the Company’s shares from PT Pyridam Internasional to Rejuve Global Investment Pte Ltd amounting to 254,736,579 shares or around 47.61% of the Company’s total shares.
The change of ownership has made Rejuve Global Investment Pte Ltd. as a controller of the Company. The takeover of the Company was announced in Harian Neraca on July 21, 2020 by Rejuve Global Investment Pte Ltd.
Then the company moved its head office to:
Sinarmas MSIG Tower 12th Floor, Jl. Jend. Sudirman No.Kav. 21, RT.10/RW.1, Kuningan, Karet, Kecamatan Setiabudi, Kota Jakarta Selatan, Jakarta 12920 – Indonesia.
In addition, in 2020 the Company started its investment in PYFA Health Singapore Pte Ltd, in amount of 990 shares or around 99.00 % of shares in such company, whereby its business activities are engaged in research and experimental development on biotechnology, life, and medical science.
In 2020, the Company obtained an ISO 9001 : 2015 certificate for Sales, Marketing, and Manufacturing of Pharmaceuticals, Natural Medicines, Household product, and Health Suplement, and also Sales and Marketing of Medical Devices issued by SGS United Kingdom Ltd with a validity period until September 9, 2023.